Quantum Computing Solution

For Cancer Research and Drug Discovery

About us

At QuanOncoLytics, we are pioneering the use of quantum computing to transform cancer research and drug discovery. Traditional methods often struggle with the complexity of cancer biology, the high cost of drug development, and the need for personalized treatments. By leveraging quantum algorithms, we aim to overcome these challenges, accelerating the discovery of novel therapies and optimizing drug design at an unprecedented scale.

Our research focuses on cutting-edge algorithms which enable precise molecular simulations critical for understanding chemical reactions and drug interactions. By applying these advancements, we help computational chemistry teams explore vast chemical spaces more efficiently, reducing the time and cost associated with developing effective cancer treatments.

At QuanOncoLytics, we believe that quantum-driven innovation will redefine the future of cancer treatment, making personalized and targeted therapies more accessible. Our mission is to bridge the gap between quantum computing and oncology, bringing hope to millions of patients worldwide.

Founding Team

Satheesh Thalapalli

Satheesh Thalapalli

Co-Founder & CEO

LinkedIn
Arun Baruah

Arun Baruah

Co-Founder & CTO

LinkedIn

Advisors

Satheesh Thalapalli

Dr. Krishnan Sivaraman Iyer

Molecular Biology

LinkedIn
Satheesh Thalapalli

Dr. Elisha R Repalle

Biochemistry

LinkedIn
dr.prafulla

Dr. Prafulla Dutta

Ex Scientist-G,Indian Council of Medical Research

LinkedIn

Team Members & Research Interns

nagarupa

Nagaroopa. T

M.Sc Biotechnology

Satheesh Thalapalli

Desai Karanam Poornima

M.Sc Biotechnology

Satheesh Thalapalli

GDK Jyoti

M.Sc Biotechnology

Abhijeet

Abhijeet Dutta

M.Tech (CS)

Sunil

Sunil Kumar

B.Tech (CS)

sandeep

Sandeep Jha

MCA